Ultrasound Guided TAP Block Versus Caudal Block in Pediatrics

NCT ID: NCT03701126

Last Updated: 2018-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-01

Study Completion Date

2019-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of pediatric regional anesthesia has increased because of its effective pain control, improved safety profile of local anesthetic agents, in addition to the introduction of ultra-sound. At present, caudal block is one of the most common regional anesthetic techniques employed in pediatric surgery. In addition to providing postoperative analgesia, caudal block significantly reduces intraoperative analgesic requirements and upper airway complications. Transversus abdominis plane (TAP) block involves infiltration of local anesthetics to the plane between the internal oblique and transversus abdominis muscles. Indeed, TAP block offers a hemodynamic stability, appropriate intra-operative analgesia and post surgical analgesia of the abdominal wall.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of pediatric regional anesthesia has increased because of its effective pain control, improved safety profile of local anesthetic agents, in addition to the introduction of ultra-sound.

At present, caudal block is one of the most common regional anesthetic techniques employed in pediatric surgery. In addition to providing postoperative analgesia, caudal block significantly reduces intraoperative analgesic requirements and upper airway complications.

However, in recent days there is a trend toward the use of peripheral nerve blockade wherever applicable, given the lower incidences of adverse effects when compared with neuron-axial techniques. Furthermore, there may be specific anatomic variations or abnormalities which preclude the use of caudal block.

The abdominal wall consists of three muscular layers, the external oblique abdominis muscle (EOAM), the internal oblique abdominis muscle (IOAM), and the tranversus abdominis muscle (TAM), and their associated fascial sheaths. The central abdominal wall also includes the rectus abdominis muscles and its associated fascial sheath. This muscular wall is innervated by nerve afferents that course through the transversus abdominis neuron-fascial plane.

Transversus abdominis plane (TAP) block involves infiltration of local anesthetics to the plane between the internal oblique and transversus abdominis muscles. Indeed, TAP block offers a hemodynamic stability, appropriate intra-operative analgesia and post surgical analgesia of the abdominal wall.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

Transversus Abdominis Plane block using 1ml/kg of bupivacaine 0.25% under ultrasound guidance

Group Type ACTIVE_COMPARATOR

Transversus Abdominis Plane Block

Intervention Type PROCEDURE

ultrasound (US) guided TAP block will be done to the patients using 0.25% bupivacaine, in a dose of (1 ml / kg).

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Dose 1ml /kg of patient body weight

Ultra-sound guidance

Intervention Type DEVICE

using superficial high frequency probe to guide regional anesthesia

group B

Caudal block using 1ml/kg of bupivacaine 0.25% under ultrasound guidance

Group Type ACTIVE_COMPARATOR

Caudal Block

Intervention Type PROCEDURE

ultrasound (US) guided caudal block will be done to the patients using 0.25% bupivacaine, in a dose of (1 ml / kg).

Bupivacaine 0.25% Injectable Solution

Intervention Type DRUG

Dose 1ml /kg of patient body weight

Ultra-sound guidance

Intervention Type DEVICE

using superficial high frequency probe to guide regional anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transversus Abdominis Plane Block

ultrasound (US) guided TAP block will be done to the patients using 0.25% bupivacaine, in a dose of (1 ml / kg).

Intervention Type PROCEDURE

Caudal Block

ultrasound (US) guided caudal block will be done to the patients using 0.25% bupivacaine, in a dose of (1 ml / kg).

Intervention Type PROCEDURE

Bupivacaine 0.25% Injectable Solution

Dose 1ml /kg of patient body weight

Intervention Type DRUG

Ultra-sound guidance

using superficial high frequency probe to guide regional anesthesia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA (American society of anesthiologists) physical status grade I-II.
* Operations not extending more than two hours.
* Unilateral surgeries.

Exclusion Criteria

* Refusal of parents.
* Urgent cases.
* Bilateral or Complicated hernias (i.e., obstructed, strangulated, irreducible …).
* Other contraindication of regional anesthesia e.g. septic focus at site of injection, patients on anticoagulant therapy or suffering from coagulopathy, allergy to local anesthetic drug.
* Prolonged operations more than two hours.
Minimum Eligible Age

3 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammed Abdullah Seliem Mekawy

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed A Refky, MD

Role: STUDY_CHAIR

Faculty of medicine, zagazig university, Egypt

Doaa M Farid, MD

Role: STUDY_CHAIR

Faculty of medicine, zagazig university, Egypt

Ayat A Amer, MD

Role: STUDY_DIRECTOR

Faculty of medicine, zagazig university, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine, Zagazig University.

Zagazig, Alsharkia, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mohammed AS Mekawy, MSc

Role: CONTACT

+201154183388

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohammed AS Mekawy, MSc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TAP/caudal block in pediatric

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.